Fundraising FoxNew Leaf Venture Partners — 2015 Investments
3 investments dated 2015 · listed companies and verified rows first · show all
Dimension Therapeutics was a Cambridge, Massachusetts biopharmaceutical company developing AAV-based gene therapies for rare liver-associated metabolic diseases like hemophilia, OTC deficiency, and glycogen storage disease.
Cambridge, US
Annalisa Jenkins(Executive Officer, Director)
BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)
Co-investorsF-Prime CapitalOrbiMed
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Reshape MedicalTrue North Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.